CervoMed CRVO
NASDAQ CRVO
$2.93 -0.04 (-1.35%)
At close: Oct 1, 2026 · 4:00 PM EDT

CervoMed (CRVO) Liabilities and Shareholders Equity (2010 - 2026)

Updated

CervoMed (CRVO) reported Liabilities and Shareholders Equity of $25.99 million for Q2 2026, down 31.7% from $38.08 million a year earlier but up 72.0% from the prior quarter.

Analysis

CervoMed (CRVO) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends

At the end of FY2025, CervoMed posted Liabilities and Shareholders Equity of $22.88 million, down 46.9% from FY2024.

  • Liabilities and Shareholders Equity has a five-year compound annual growth rate of -3.8% (FY2020 to FY2025).
  • By year, Liabilities and Shareholders Equity came in at $43.08 million in FY2024 (+332.0%), $9.97 million in FY2023 (+139.9%), $4.16 million in FY2022 (-89.0%) and $37.84 million in FY2021 (+36.5%).
  • Five-year quarterly Liabilities and Shareholders Equity spans a low of $3.36 million in Q2 2023 and a high of $53.19 million in Q2 2024.
  • Year over year, Liabilities and Shareholders Equity has now declined in each of the last five quarters, with growth averaging 101.9% over the last eight quarters.
  • The high point for year-over-year Liabilities and Shareholders Equity in five years was Q1 2025 (growth of 382.4%); the low point was Q4 2022 (a decline of 89.0%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $15.11 million (Q1 2026), $22.88 million (Q4 2025) and $30.61 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 201.06 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 135.12 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 129.80 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 122.03 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 115.83 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 95.64 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 49.36 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 201.13 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 27.42 Bn
10 CervoMed 30.43 Mn 30.43 Mn - 25.99 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 25.99 Mn
Mar 31, 2026 15.11 Mn
Dec 31, 2025 22.88 Mn
Sep 30, 2025 30.61 Mn
Jun 30, 2025 38.08 Mn
Mar 31, 2025 38.58 Mn
Dec 31, 2024 43.08 Mn
Sep 30, 2024 48.88 Mn
Jun 30, 2024 53.19 Mn
Mar 31, 2024 8.00 Mn
Dec 31, 2023 9.97 Mn
Sep 30, 2023 12.04 Mn
Jun 30, 2023 3.36 Mn
Mar 31, 2023 3.94 Mn
Dec 31, 2022 4.16 Mn
Sep 30, 2022 26.32 Mn
Jun 30, 2022 29.18 Mn
Mar 31, 2022 33.57 Mn
Dec 31, 2021 37.84 Mn
Sep 30, 2021 40.88 Mn
API Access

CervoMed Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=CRVO&period=max&api_key=YOUR_API_KEY